| Secondary |
| Drug Use For Unknown Indication |
20.5% |
| Product Used For Unknown Indication |
14.3% |
| Angina Pectoris |
10.5% |
| Hypertension |
6.2% |
| Diabetic Foot |
5.4% |
| Bronchitis |
4.7% |
| Prophylaxis |
4.7% |
| Atrial Fibrillation |
3.9% |
| Depression |
3.5% |
| Arrhythmia |
3.1% |
| Asthma |
3.1% |
| Essential Hypertension |
3.1% |
| Cardiac Failure |
2.7% |
| Hypercholesterolaemia |
2.7% |
| Accidental Exposure |
2.3% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Thrombosis Prophylaxis |
2.3% |
| Aortic Valve Disease |
1.6% |
| Dysuria |
1.6% |
| Hypothyroidism |
1.6% |
|
| Renal Failure Acute |
15.9% |
| Tendon Rupture |
9.1% |
| Toxic Skin Eruption |
9.1% |
| Disseminated Intravascular Coagulation |
6.8% |
| Vitamin K Deficiency |
6.8% |
| Fall |
4.5% |
| Overdose |
4.5% |
| Renal Failure |
4.5% |
| Septic Shock |
4.5% |
| Shock Haemorrhagic |
4.5% |
| Subarachnoid Haemorrhage |
4.5% |
| Thrombocytopenic Purpura |
4.5% |
| Urinary Retention |
4.5% |
| Coma |
2.3% |
| Decreased Appetite |
2.3% |
| Hepatocellular Injury |
2.3% |
| Idiopathic Thrombocytopenic Purpura |
2.3% |
| Multiple Drug Overdose |
2.3% |
| Normochromic Normocytic Anaemia |
2.3% |
| Pemphigoid |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
42.3% |
| Product Used For Unknown Indication |
12.2% |
| Hypertension |
6.2% |
| Ill-defined Disorder |
5.3% |
| Anxiety |
3.3% |
| Prophylaxis |
2.7% |
| Angina Pectoris |
2.6% |
| Cardiac Failure |
2.6% |
| Thrombosis Prophylaxis |
2.6% |
| Dementia Alzheimer's Type |
2.4% |
| Depression |
2.4% |
| Urinary Tract Infection |
2.2% |
| Diabetes Mellitus |
2.0% |
| Essential Hypertension |
2.0% |
| Mantle Cell Lymphoma |
2.0% |
| Diabetes Mellitus Non-insulin-dependent |
1.8% |
| Arrhythmia |
1.6% |
| Pain |
1.6% |
| Atrial Fibrillation |
1.3% |
| Abdominal Pain |
1.1% |
|
| Renal Failure |
11.8% |
| Renal Failure Acute |
10.8% |
| Hyponatraemia |
6.5% |
| Melaena |
6.5% |
| Pruritus |
6.5% |
| Vascular Dementia |
6.5% |
| Rhabdomyolysis |
5.4% |
| Death |
4.3% |
| Hepatitis Cholestatic |
4.3% |
| Pancreatitis Acute |
4.3% |
| Somnolence |
4.3% |
| Drug Interaction |
3.2% |
| Hyperkalaemia |
3.2% |
| International Normalised Ratio Increased |
3.2% |
| Malaise |
3.2% |
| Muscle Haemorrhage |
3.2% |
| Septic Shock |
3.2% |
| Subdural Haematoma |
3.2% |
| Syncope |
3.2% |
| Toxic Skin Eruption |
3.2% |
|
| Interacting |
| Arrhythmia |
22.2% |
| Essential Hypertension |
22.2% |
| Hypertension |
22.2% |
| Prophylaxis |
22.2% |
| Angina Pectoris |
11.1% |
|
| Tibia Fracture |
80.0% |
| Traumatic Haematoma |
20.0% |
|
